UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation

Bioorganic & medicinal chemistry letters, 2013-07, Vol.23 (13), p.3741-3748

2013

Volltextzugriff (PDF)

Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors

ACS medicinal chemistry letters, 2017-09, Vol.8 (9), p.975-980

2017

Volltextzugriff (PDF)

Discovery and Profiling of a Selective and Efficacious Syk Inhibitor

Journal of medicinal chemistry, 2015-02, Vol.58 (4), p.1950-1963

2015

Volltextzugriff (PDF)

Preclinical pharmacokinetics and metabolism of MAK683, a clinical stage selective oral embryonic ectoderm development (EED) inhibitor for cancer treatment

Xenobiotica, 2022-01, Vol.52 (1), p.65-78

2022

Volltextzugriff (PDF)

Evaluation of relative MS response factors of drug metabolites for semi‐quantitative assessment of chemical liabilities in drug discovery

Journal of mass spectrometry., 2017-04, Vol.52 (4), p.210-217

2017

Volltextzugriff (PDF)

Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors

ACS medicinal chemistry letters, 2016-08, Vol.7 (8), p.762-767

2016

Volltextzugriff (PDF)

Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors

Journal of medicinal chemistry, 2016-08, Vol.59 (16), p.7544-7560

2016

Volltextzugriff (PDF)

Micropreparative isolation and NMR structure elucidation of metabolites of the drug candidate 1-isopropyl-4-(4-isopropylphenyl)-6-(prop-2-yn-1-yloxy) quinazolin-2(1H)-one from rat bile and urine

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2015-05, Vol.989, p.1-10

2015

Volltextzugriff (PDF)

Design of A Metabolically Stable Tritium‐Tracer of the PI 3K δ ‐Inhibitor CDZ 173 (Leniolisib) as a Tool to Study Liver Metabolites

Helvetica chimica acta, 2018-06, Vol.101 (6)

2018

Volltextzugriff (PDF)

Increasing metabolic stability via the deuterium kinetic isotope effect: An example from a proline-amide-urea aminothiazole series of phosphatidylinositol-3 kinase alpha inhibitors

Bioorganic & medicinal chemistry letters, 2016-10, Vol.26 (19), p.4729-4734

2016

Volltextzugriff (PDF)

Identification and optimisation of 4,5-dihydrobenzo[1,2-d:3,4-d]bisthiazole and 4,5-dihydrothiazolo[4,5-h]quinazoline series of selective phosphatidylinositol-3 kinase alpha inhibitors

Bioorganic & medicinal chemistry letters, 2015-09, Vol.25 (17), p.3575-3581

2015

Volltextzugriff (PDF)

Orally bioavailable Syk inhibitors with activity in a rat PK/PD model

Bioorganic & medicinal chemistry letters, 2015-10, Vol.25 (20), p.4642-4647

2015

Volltextzugriff (PDF)

Design of A Metabolically Stable Tritium‐Tracer of the PI3Kδ‐Inhibitor CDZ173 (Leniolisib) as a Tool to Study Liver Metabolites

Helvetica chimica acta, 2018-06, Vol.101 (6), p.n/a

2018

Volltextzugriff (PDF)

Syk inhibitors with high potency in presence of blood

Bioorganic & medicinal chemistry letters, 2014-05, Vol.24 (10), p.2278-2282

2014

Volltextzugriff (PDF)

Corrigendum to “Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation” [Bioorg. Med. Chem. Lett. 23 (2013) 3741–3748]

Bioorganic & medicinal chemistry letters, 2013-08, Vol.23 (16), p.4723-4723

2013

Volltextzugriff (PDF)

Exploring subtype selectivity and metabolic stability of a novel series of ligands for the benzodiazepine binding site of the GABA A receptor

Bioorganic & medicinal chemistry letters, 2011-03, Vol.21 (5), p.1523-1526

2011

Volltextzugriff (PDF)

Exploring subtype selectivity and metabolic stability of a novel series of ligands for the benzodiazepine binding site of the GABAA receptor

Bioorganic & medicinal chemistry letters, 2011-03, Vol.21 (5), p.1523-1526

2011

Volltextzugriff (PDF)

Exploring subtype selectivity and metabolic stability of a novel series of ligands for the benzodiazepine binding site of the GABA sub(A receptor)

Bioorganic & medicinal chemistry letters, 2011-03, Vol.21 (5), p.1523-1526

2011

Volltextzugriff (PDF)

Abstract 1922: 2-Aminothiazoles as potent and selective PI3Kalpha inhibitors: Discovery of NVP-BYL719 and structural basis for the isoform selectivity

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.1922-1922

2012

Volltextzugriff (PDF)

Benzimidazoles as Potent and Orally Active mGlu5 Receptor Antagonists with an Improved PK Profile

ACS medicinal chemistry letters, 2011-01, Vol.2 (1), p.58-62

2011

Volltextzugriff (PDF)

Cytochrome P-450-induced cytotoxicity of mitoxantrone by formation of electrophilic intermediates

Cancer research (Chicago, Ill.), 1993-11, Vol.53 (21), p.5135-5142

1993

Volltextzugriff (PDF)

13C-Markierung der Seitenketten von Mitoxantrone

Journal of labelled compounds & radiopharmaceuticals, 1989-01, Vol.27 (1), p.91-101

1989

Volltextzugriff (PDF)

Pharmacokinetics and metabolism of mitoxantrone : a review

Clinical pharmacokinetics, 1990-05, Vol.18 (5), p.365-380

1990

Volltextzugriff (PDF)

Quantitation of busulfan in plasma by high-performance liquid chromatography using postcolumn photolysis

Journal of chromatography, 1990, Vol.532 (2), p.429-437

1990

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(35)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(21)
Pharmacology & Pharmacy
(14)
Animals
(12)
Chemistry, Medicinal
(12)
Humans
(12)
Physical Sciences
(11)
Chemistry
(9)
Rats
(8)
Structure-Activity Relationship
(8)
Biological And Medical Sciences
(7)
Chemistry, Organic
(6)
Medical Sciences
(6)
Molecular Structure
(6)
Protein Kinase Inhibitors - Chemistry
(6)
Protein Kinase Inhibitors - Pharmacology
(6)
Male
(5)
Models, Molecular
(5)
Rats, Sprague-Dawley
(5)
Antineoplastic Agents
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation

Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors

Discovery and Profiling of a Selective and Efficacious Syk Inhibitor

Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies

Preclinical pharmacokinetics and metabolism of MAK683, a clinical stage selective oral embryonic ectoderm development (EED) inhibitor for cancer treatment

Evaluation of relative MS response factors of drug metabolites for semi‐quantitative assessment of chemical liabilities in drug discovery

Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors

Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors

Micropreparative isolation and NMR structure elucidation of metabolites of the drug candidate 1-isopropyl-4-(4-isopropylphenyl)-6-(prop-2-yn-1-yloxy) quinazolin-2(1H)-one from rat bile and urine

Design of A Metabolically Stable Tritium‐Tracer of the PI 3K δ ‐Inhibitor CDZ 173 (Leniolisib) as a Tool to Study Liver Metabolites

Increasing metabolic stability via the deuterium kinetic isotope effect: An example from a proline-amide-urea aminothiazole series of phosphatidylinositol-3 kinase alpha inhibitors

Identification and optimisation of 4,5-dihydrobenzo[1,2-d:3,4-d]bisthiazole and 4,5-dihydrothiazolo[4,5-h]quinazoline series of selective phosphatidylinositol-3 kinase alpha inhibitors

Orally bioavailable Syk inhibitors with activity in a rat PK/PD model

Design of A Metabolically Stable Tritium‐Tracer of the PI3Kδ‐Inhibitor CDZ173 (Leniolisib) as a Tool to Study Liver Metabolites

Syk inhibitors with high potency in presence of blood

Corrigendum to “Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation” [Bioorg. Med. Chem. Lett. 23 (2013) 3741–3748]

Exploring subtype selectivity and metabolic stability of a novel series of ligands for the benzodiazepine binding site of the GABA A receptor

Exploring subtype selectivity and metabolic stability of a novel series of ligands for the benzodiazepine binding site of the GABAA receptor

Exploring subtype selectivity and metabolic stability of a novel series of ligands for the benzodiazepine binding site of the GABA sub(A receptor)

Abstract 1922: 2-Aminothiazoles as potent and selective PI3Kalpha inhibitors: Discovery of NVP-BYL719 and structural basis for the isoform selectivity

Benzimidazoles as Potent and Orally Active mGlu5 Receptor Antagonists with an Improved PK Profile

Cytochrome P-450-induced cytotoxicity of mitoxantrone by formation of electrophilic intermediates

13C-Markierung der Seitenketten von Mitoxantrone

Pharmacokinetics and metabolism of mitoxantrone : a review

Quantitation of busulfan in plasma by high-performance liquid chromatography using postcolumn photolysis

Suchergebnisse filtern